文献速递产科母胎医学

赞比亚女性联合队列中母亲人类免疫缺陷病毒感染与子痫前期的关系

Maternal Human Immunodeficiency Virus and Preeclampsia Among a Combined Cohort of Zambian Women.
PubMed 文献 · Obstet Gynecol · 2025-06-12

该研究联合赞比亚卢萨卡同一机构2015至2022年的一项观察性队列和两项随机试验的4078名孕妇,评估母亲HIV感染与子痫前期的关联。在标准化母亲年龄、初产和入组日历时间后,HIV感染与较低的子痫前期风险相关(相对风险0.42;95%CI,0.26-0.59;风险差-3.5%;95%CI,-4.9至-2.1)。

要点

  • 联合队列共4078名女性,186名(4.6%)诊断为子痫前期。
  • HIV感染者子痫前期风险相对风险0.42(95%CI,0.26-0.59),风险差-3.5%(95%CI,-4.9至-2.1)。
  • 按孕前抗逆转录病毒治疗暴露、可检测病毒载量及入组时CD4计数分层后,风险降低持续存在。

核心结论

  • 在该表型明确的队列中,HIV感染女性相比无HIV感染女性子痫前期发生率更低。

研究设计与样本

  • 联合一项观察性队列和两项随机试验,均于2015年至2022年在赞比亚卢萨卡同一机构开展,共纳入4078名女性。
  • 暴露为母亲HIV感染,主要结局为子痫前期,采用边缘标准化(参数g公式)估计风险。
  • 抗逆转录病毒治疗暴露和HIV疾病严重程度(病毒载量、CD4计数)作为效应修饰因子评估。

主要发现

  • 4078名女性中186名(4.6%)诊断子痫前期,其中HIV感染女性1590名中43名(2.7%),无HIV感染女性2488名中143名(5.8%)。
  • HIV感染女性中73.2%孕前已接受抗逆转录病毒治疗,56.7%入组时(中位15周)病毒载量检测不到。
  • 标准化母亲年龄、初产和入组日历时间后,HIV感染与较低子痫前期风险相关(相对风险0.42;95%CI,0.26-0.59;风险差-3.5%;95%CI,-4.9至-2.1)。
  • 按孕前抗逆转录病毒治疗暴露、可检测病毒载量及入组时CD4计数分层后,风险降低持续存在;采用更严格的重度子痫前期定义时结果相似。

关键数值与推荐

  • 子痫前期定义:妊娠20周及以后新发高血压(收缩压≥140 mm Hg或舒张压≥90 mm Hg)伴蛋白尿(1+或更高);或慢性高血压者新发蛋白尿(1+或更高)且无尿路感染;或诊断为重度子痫前期。
  • 重度子痫前期定义:新发重度范围血压(收缩压≥160 mm Hg或舒张压≥110 mm Hg);或子痫发作;或临床医生因子痫前期 initiated 37周前早产。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the association between maternal HIV infection and preeclampsia. We hypothesized that maternal HIV infection would be associated with a lower risk of preeclampsia, potentially due to HIV-related immunomodulatory effects. METHODS: We combined participants from one observational cohort and two randomized trials conducted at the same facilities in Lusaka, Zambia between 2015 and 2022. The exposure of interest was maternal HIV infection, and the primary outcome was preeclampsia, defined as 1) new-onset (at or after 20 weeks of gestation) hypertension (systolic blood pressure [BP] 140 mm Hg or higher or diastolic BP 90 mm Hg or higher) with concurrent proteinuria (1+ or higher), 2) new onset proteinuria (1+ or higher) in participants with chronic hypertension in the absence of urinary tract infection, or 3) diagnosis of severe preeclampsia. We defined severe preeclampsia as 1) new-onset severe-range BP (systolic 160 mm Hg or higher or diastolic 110 mm Hg or higher), 2) eclamptic seizure, or 3) clinician-initiated preterm delivery (before 37 weeks of gestation) for preeclampsia. Using marginal standardization (parametric g-formula), we estimated the risk of preeclampsia associated with HIV infection. Antiretroviral therapy (ART) exposure and HIV disease severity (viral load, CD4 counts) were assessed as effect modifiers. RESULTS: Of 4,078 women included in the combined cohort, 186 (4.6%) were diagnosed with preeclampsia, including 43 (2.7%) of 1,590 women with HIV infection and 143 (5.8%) of 2,488 women without HIV infection. Of those with HIV infection, 73.2% were on prepregnancy ART, and 56.7% had an undetectable viral load at study enrollment (median 15 weeks). In analyses standardizing for maternal age, nulliparity, and calendar time of enrollment, HIV infection was associated with lower preeclampsia risk (relative risk 0.42; 95% CI, 0.26-0.59; risk difference -3.5%; 95% CI, -4.9 to -2.1). This reduced risk persisted when stratifying by prepregnancy ART exposure, detectable viral load, and CD4 count at enrollment; findings were similar when applying the more stringent definition of severe preeclampsia. CONCLUSION: In this well-phenotyped cohort, women with HIV infection were less likely to have preeclampsia compared with those without HIV infection.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Rittenhouse KJ, Kasaro MP, Spelke MB, et al. Maternal Human Immunodeficiency Virus and Preeclampsia Among a Combined Cohort of Zambian Women. Obstet Gynecol. 2025. PMID: 40839874. doi:10.1097/AOG.0000000000005970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。